PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
PLOS ONE | https://doi.org/10.1371/journal.pone.0192765 February 23, 2018
Developed in collaboration with the International Council of AIDS Service Organizations (ICASO)
Strengthening Community responses to HIv Treatment and Prevention
Unite for Children
First Edition
From choice, a world of possibilities
Want to change the world? Here's how...
"i asked: 'Why doesn't somebody do something?' Then I realized I was somebody"
A practical toolkit for young people who are passionate about advancing HIV and sexual and reproductive health and rights through national advocacy in the post-2015 agenda.
Les conséquences néfastes de la mauvaise gestion et les faits de corruption dans le domaine de la
santé ont amené l’Organisation mondiale de la Santé (OMS) à mettre en place depuis 2004, un
programme de bonne gouvernance qui vise à améliorer les mesures de transparence dans
l’exercice... des fonctions du secteur pharmaceutique.
Notre pays, le Bénin, ayant souscrit à ce programme en 2007, l’OMS a commis des experts qui ont
procédé à l’évaluation des fonctions essentielles du secteur pharmaceutique public béninois.
De l’analyse des résultats de cette évaluation réalisée conformément aux normes admises par
l’OMS en la matière, il ressort qu’en République du Bénin, la gestion des produits
pharmaceutiques dans le secteur public présente une vulnérabilité modérée à la corruption.
Sur les six (06) fonctions ayant fait l’objet de l’évaluation, seule celle liée au contrôle de la
promotion des médicaments présente une forte vulnérabilité à la corruption en raison de la faible
note de 3,428 sur 10 dont elle a été créditée.
more
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
HIV testing services
Policy Brief
November 2018
WHO/CDS/HIV/18.48
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more
UNAIDS 2016 / Meeting Report
UNAIDS | 2016–2021 Strategy
Accessed: 20.11.2019